ONdrugDelivery - ONdrugDelivery - drug delivery industry specialised b2b information

#137_Sept2022_Nemera_hero

OFFERING A SMART AND SUSTAINABLE ON-BODY INJECTOR FOR CHRONICALLY ILL PATIENTS

Cécile Gross discusses the unmet drug delivery needs in chronic diseases, and details how Nemera’s answer – the Symbioze^® on-body injector – fulfils these needs.

THE EVOLUTION OF WEARABLES – REPRESENTING THE VOICE OF THE ENTIRE ECOSYSTEM

Lauren Orme, Victoria Morgan and Shari Krusniak consider the current landscape for on-body delivery systems and discuss how West Pharmaceutical Services is responding to the demands of various stakeholders.

#137_Sep_2022_Stevenato_Featured

DEVELOPING AN ON-BODY PLATFORM FOR EFFECTIVE POST-OPERATIVE PAIN MANAGEMENT

Paolo Golfetto and Sheldon Moberg discuss a collaboration between Stevanato Group and Bexson Biomedical that meets an urgent unmet patient need.

ON-BODY DELIVERY SYSTEMS – NEWS AND TRENDS

ON-BODY DELIVERY SYSTEMS – NEWS AND TRENDS

Tom Oakley discusses the current state of play in the on-body delivery system space, reviews recent milestones and proposes directions for the future.

A NEW MEMS ENGINE FOR LARGE-VOLUME SUBCUTANEOUS INJECTORS

Dr Jiunn-Ru Lai

MicroMED Co Ltd

A NEW MEMS ENGINE FOR LARGE-VOLUME SUBCUTANEOUS INJECTORS

Jiunn-Ru Lai, Tsung-Chieh Cheng and Brian Li discuss how MicroMED’s Primary Actuator technology for driving high-volume, high-viscosity injection devices compares with current spring and motor technologies.

ACCELERATING DEVELOPMENT OF SUBCUTANEOUS DELIVERY OF LARGE-VOLUME BIOLOGICS

ACCELERATING DEVELOPMENT OF SUBCUTANEOUS DELIVERY OF LARGE-VOLUME BIOLOGICS

Tom Mayer discusses how Sonceboz’s vial-based on-body injector – the LVI-V – can expedite the launch of large-volume SC delivery of biologics by leveraging existing primary container technology, reducing associated risks and total cost of ownership.

KEY CONSIDERATIONS WHEN SPECIFYING A MOTION SYSTEM FOR WEARABLE INJECTORS

Dave Beckstoffer

KEY CONSIDERATIONS WHEN SPECIFYING A MOTION SYSTEM FOR WEARABLE INJECTORS

The reliable performance of a wearable drug delivery device is understandably paramount, so optimising the motion solution that drives it is crucial. Dave Beckstoffer discusses how best to achieve this and ensure the best match between the motion solution and the characteristics of the specified drug or drug range.

WEARABILITY AND USABILITY OF THE YPSODOSE 10 mL PATCH INJECTOR

WEARABILITY AND USABILITY OF THE YPSODOSE 10 mL PATCH INJECTOR

Jakob Lange discusses the results of a recently published study into the usability and wearability of the YpsoDose 10 mL patch injector, providing a summary of the insights acquired during the study.

MIKRON AUTOMATION: A LEADER IN THE COMPLEX ASSEMBLY OF ON-BODY INJECTORS

Jean-François Bauer

Mikron Automation

MIKRON AUTOMATION: A LEADER IN THE COMPLEX ASSEMBLY OF ON-BODY INJECTORS

Mikron Automation sets out its expertise in the assembly of on-body injectors, a field requiring exception precision and innovative approaches, as well as discussing how Mikron works with its partners from the very earliest stages of device development to help ensure projects are completed efficiently and successfully.

DRUG DELIVERY DEVICES THROUGHOUT THE DRUG DEVELOPMENT CYCLE

Dr Ori Ben-David

DRUG DELIVERY DEVICES THROUGHOUT THE DRUG DEVELOPMENT CYCLE

Ori Ben-David discusses the considerations that must be made over the course of injectable drug development and how Eitan Medical’s Sapphire™ and Sorrel™ platforms offer pharmaceutical companies a full suite of device tools from early discovery through to commercialisation.

FLEXIBLE CARE – ENABLE WEARABLE DELIVERY

Enable Injections

FLEXIBLE CARE – ENABLE WEARABLE DELIVERY

Jennifer Estep and Mehul Desai discuss the benefits for patients and healthcare providers of innovative subcutaneous delivery.

USING MAGNETIC SENSORS FOR METERING DRUG VOLUME IN WEARABLE INJECTORS

Coto Technology

USING MAGNETIC SENSORS FOR METERING DRUG VOLUME IN WEARABLE INJECTORS

Tim Reskerdiscusses the application of tunnelling magnetoresistive sensing technology to on-body injectors, including the vital function of accurately measuring the delivered dose, as well as other functions, such as powering on the device.

IMPROVE YOUR BIOPHARMACEUTICAL WORKFLOW: 6 BENEFITS OF SINGLE-USE SYSTEM TECHNOLOGIES

IMPROVE YOUR BIOPHARMACEUTICAL WORKFLOW: 6 BENEFITS OF SINGLE-USE SYSTEM TECHNOLOGIES

Sara Dorman discusses the benefits of single-use systems, including how they help accelerate a drug product’s journey to market securely and more sustainably.

FROM SIMULATION TO SPRING SATISFACTION

INDUSTRIALISATION

Drew Jelgerhuis

Scherdel Medtec North America

FROM SIMULATION TO SPRING SATISFACTION

Drew Jelgerhuis discusses the power of simulation to enhance a drug delivery device design project, including faster development times and reduced costs.

INDUSTRIALISATION OF PHARMACEUTICAL AND MEDICAL DEVICES IN THE SCIENTIFIC MOULDING APPROACH

INDUSTRIALISATION

INDUSTRIALISATION OF PHARMACEUTICAL AND MEDICAL DEVICES IN THE SCIENTIFIC MOULDING APPROACH

Thomas Rudolph, Markus Reil, Stefan Schumann and Tobias Weigert discuss Gerresheimer’s strategy for managing potential risks across the entire product lifecycle.

INTERVIEW: RENAN JOEL, CONNECT IN PHARMA CONFERENCE

INTERVIEW: RENAN JOEL, CONNECT IN PHARMA CONFERENCE

Renan Joel, Easyfairs' Divisional Director Packaging – UK, France, Italy & Switzerland, talks with ONdrugDelivery about the upcoming inaugural Connect in Pharma conference in Geneva.

INDUSTRIALISATION AND SCALE-UP OF DRUG DELIVERY DEVICES

INDUSTRIALISATION

Dr Barry McDermott

West Pharmaceutical Services

INDUSTRIALISATION AND SCALE-UP OF DRUG DELIVERY DEVICES

Barry McDermott and Shari Krusniak look at the manufacturing processes involved in bringing a new drug delivery system and formulation to market.

SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING

SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING

Jeff Lowe considers single-use systems and looks at their role in the future of biopharmaceutical processing.

DISSECTING THE DELICATE DELIVERY PROCESS FOR OCULAR GENE THERAPY

Dr Yongdong Zhou

DISSECTING THE DELICATE DELIVERY PROCESS FOR OCULAR GENE THERAPY

Yongdong Zhou considers the challenges of ocular gene therapy delivery approaches.

HOLISTIC DEVELOPMENT & INDUSTRIALISATION OF DRUG DELIVERY DEVICES & COMBINATION PRODUCTS

INDUSTRIALISATION

HOLISTIC DEVELOPMENT & INDUSTRIALISATION OF DRUG DELIVERY DEVICES & COMBINATION PRODUCTS

Mark Tunkel and Niyati Sapatnekar discuss Nemera’s holistic approach to development and industrialisation.

INTERVIEW: Piyush Agarwal, Tjoapack

INTERVIEW: Piyush Agarwal, Tjoapack

Piyush Agarwal talks with ONdrugDelivery about the current state of the injectable pharmaceuticals market and how working with a specialist contract packaging organisation can help pharma companies navigate their product through this rapidly evolving sector and deliver their product to market on time.

NEXT-GENERATION CAPSULE FILLING: MG2 AND THE DM² PROJECT

INDUSTRIALISATION

NEXT-GENERATION CAPSULE FILLING: MG2 AND THE DM² PROJECT

MG2 introduces the UK Made Smarter Innovation - Digital Medicine Manufacturing (DM²) Research Centre, which it has recently joined as an industrial partner, and describes how it will develop an AI-driven microscale capsule filling system for the selection of formulation and process parameters.

ROUNDTABLE: TRENDS AND INNOVATIONS IN ORAL DRUG DELIVERY

ROUNDTABLE: TRENDS AND INNOVATIONS IN ORAL DRUG DELIVERY

Michael Morgen of Lonza Bend, Torkel Gren of Recipharm, and Yogesh Sadhale of Metrics Contract Services, discuss the current trends and innovations influencing oral drug delivery development and what their respective companies can offer to pharma in this space.

INFLUENCE OF ADDITIVES ON THE ELECTROSTATIC CHARGE BUILD-UP OF EXCIPIENTS

Dr Aurelien Neveu

INFLUENCE OF ADDITIVES ON THE ELECTROSTATIC CHARGE BUILD-UP OF EXCIPIENTS

Aurélien Neveu, Devang Patel and Filip Francqui present a study investigating the influence of additives on the tribocharging behaviour of two excipients using Granutools’ GranuCharge instrument.

Video: Introducing Connect in Pharma

Video: Introducing Connect in Pharma

This video introduces Connect in Pharma, the new annual event dedicated to advanced pharmaceuticals downstream from the molecule and biotechnology, designed to drive innovation, business and new partnerships in four key areas: innovative packaging; drug delivery systems; CMO/CDMO; and filling and assembly.

MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE

Chelsea Williams

MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE

Chelsea Williams, Nagisa Kobashi and Nils Weber discuss the digital transformation of injectables, where drug formulation and device are enmeshed within a connected ecosystem powered by patient data.

A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!

BD (Becton Dickinson & Company)

A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!

Aurélie Pager and Mircea Despa follow up on an article published in the December 2021 issue of ONdrugDelivery. BD has now completed a human factors study assessing the usability, acceptance and ease of use of its connected injection prototype for clinical trials.

PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS

Dr Andreas Schneider

PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS

Andreas Schneider and Philippe Müller discuss the potential benefits and challenges of implementing connected device-digital solutions within the healthcare sector to improve the treatment of chronic conditions.

FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS

Dr Bernard Vrijens

FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS

Bernard Vrijens looks at the effect of decentralised clinical trials on medication adherence in clinical studies.

CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS

Bespak by Recipharm

CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS

Gemma Wood explores connected device development trends, the patient-centric benefits the technology has to offer and how, with the help of experienced manufacturing partners connected to key enabling technology partners, they can develop products that deliver improved patient outcomes.

A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM

A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM

Marcel Botha, Andreas Bilstein, Houssam Elghobary and Rouven Kraus discuss the benefits of the Validose digital health platform for the safe delivery of high-value and/or high-risk products.

THE SMART INHALER REVOLUTION: ARE WE THERE YET?

Cambridge Design Partnership

THE SMART INHALER REVOLUTION: ARE WE THERE YET?

Mark Allen, David Blakey and Karla Sanchez discuss the benefits of smart inhalers and how they could influence the commercialisation of respiratory drugs in the future.

HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES

HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES

Ben Cox discusses the key challenges, principles and advantages of following a user-experience approach to digital health technologies in clinical trials.

HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE

HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE

Sylvia Kaiser-Kershaw discusses how recent near-field communication tagging advancements can enable pharmaceutical companies to protect the authenticity and integrity of their products, while also making it easier for healthcare professionals and patients to use medications more effectively through intelligent drug delivery systems.

NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED

NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED

Louisa Harvey, Alper Hulusi, Bjarki Holm and Stefan Olafsson introduce their quick and accessible app for identifying whether or not a patient is likely to take their medication as prescribed.

CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY

Gabrielle Whitworth-Smith

CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY

Gabrielle Whitworth-Smith and Thomas Watts look at the benefits and risks associated with cloud connectivity and the accompanying cybersecurity challenges.

CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND

Napoleon Monroe

CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND

Napoleon Monroe looks back at the factors that influenced the underwhelming uptake of connectivity-enabling technologies in the healthcare sector over the first two decades of the 21st century, how the covid-19 pandemic changed everything and what current healthcare challenges connectivity might solve.

SUPPORTING PATIENTS ON THE ROAD TO SELF-CARE

SUPPORTING PATIENTS ON THE ROAD TO SELF-CARE

Michael Earl discusses the importance of transitioning current healthcare models to embrace patient self-management and how advanced drug delivery device technologies, such as connectivity, can ease this burden on overstretched healthcare services.

SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW

SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW

Paul Edalat and Mehdi Hatamian take an in-depth look at medication non-adherence and how technology can be used to improve compliance rates and optimise patient outcomes.

1
2
3
…
31
Next

See what ondrugdelivery's readers and contributors think

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.

Top